Objectives. To determine whether deep brain stimulation is an effective treatment for neuropathic pain of varied etiology. Material and Methods. Thirty-four patients with intractable neuropathic pain were prospectively studied using visual analog scores, McGill Pain Questionnaire, and Quality of Life Questionnaires (EUROQOL EQ-5D VAS, and SF-36 v-2). Patients had either deep brain stimulation of either the periventricular gray or ventroposterolateral nucleus of the thalamus, or both. Results. Seventy-six percent of patients underwent permanent implantation. Overall reduction of pain intensity was 54%. The burning component of pain improved by 77%. Health-related quality of life improved by 38%. Conclusions. Deep brain stimulation is an ...
Deep brain stimulation (DBS) is a neurosurgical intervention whose efficacy, safety, and utility hav...
Chronic neuropathic pain affects 7%-10% of the population. Deep brain stimulation (DBS) has shown va...
OBJECT: Chronic neuropathic pain is estimated to affect 3-4.5% of the worldwide population, posing a...
Objectives. To determine whether deep brain stimulation is an effective treatment for neuropathic p...
Objectives:?To determine whether deep brain stimulation is an effective treatment for neuropathic pa...
The objective of this study is to determine the usefulness of single-patient, randomised, controlled...
Deep brain stimulation (DBS) of the periventricular/periaqueductal gray area and sensory thalamus ca...
UNLABELLED: Deep brain stimulation (DBS) of the periventricular/periaqueductal gray area and sensory...
The treatment of neuropathic pain remains a public health concern. A growing cohort of patients is p...
The aim of this study was to determine the efficacy of deep brain stimulation (DBS) in the treatment...
Deep brain stimulation (DBS) has been used to treat intractable pain for over 50 years. Variations i...
Deep brain stimulation (DBS) has been used to treat intractable pain for over 50 years. Variations i...
Object Chronic neuropathic pain is estimated to affect 3–4.5% of the worldwide population, posing a ...
Deep brain stimulation (DBS) is a neurosurgical intervention the efficacy, safety, and utility of wh...
Our aim was to asses the efficacy of deep brain stimulation in post-stroke neuropathic pain. Since 2...
Deep brain stimulation (DBS) is a neurosurgical intervention whose efficacy, safety, and utility hav...
Chronic neuropathic pain affects 7%-10% of the population. Deep brain stimulation (DBS) has shown va...
OBJECT: Chronic neuropathic pain is estimated to affect 3-4.5% of the worldwide population, posing a...
Objectives. To determine whether deep brain stimulation is an effective treatment for neuropathic p...
Objectives:?To determine whether deep brain stimulation is an effective treatment for neuropathic pa...
The objective of this study is to determine the usefulness of single-patient, randomised, controlled...
Deep brain stimulation (DBS) of the periventricular/periaqueductal gray area and sensory thalamus ca...
UNLABELLED: Deep brain stimulation (DBS) of the periventricular/periaqueductal gray area and sensory...
The treatment of neuropathic pain remains a public health concern. A growing cohort of patients is p...
The aim of this study was to determine the efficacy of deep brain stimulation (DBS) in the treatment...
Deep brain stimulation (DBS) has been used to treat intractable pain for over 50 years. Variations i...
Deep brain stimulation (DBS) has been used to treat intractable pain for over 50 years. Variations i...
Object Chronic neuropathic pain is estimated to affect 3–4.5% of the worldwide population, posing a ...
Deep brain stimulation (DBS) is a neurosurgical intervention the efficacy, safety, and utility of wh...
Our aim was to asses the efficacy of deep brain stimulation in post-stroke neuropathic pain. Since 2...
Deep brain stimulation (DBS) is a neurosurgical intervention whose efficacy, safety, and utility hav...
Chronic neuropathic pain affects 7%-10% of the population. Deep brain stimulation (DBS) has shown va...
OBJECT: Chronic neuropathic pain is estimated to affect 3-4.5% of the worldwide population, posing a...